Clinical Trial Update: Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing tigecycline to ampicillin-sulbactam or amoxicillin-clavulanate for skin and soft tissue infections, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infections

Drugs mentioned

• Ampicillin-sulbactam (Ampicillin-sulbactam)
• Tigecycline (tigecycline)
• amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Skin Diseases, Bacterial | Phase 4 | Status: COMPLETED | Results posted: 2012-08-09